Advanced

Toll-Like Receptor 4 Promoter Polymorphisms: Common TLR4 Variants May Protect against Severe Urinary Tract Infection.

Ragnarsdottir, Bryndis LU ; Jönsson, Klas LU ; Urbano, Alexander; Grönberg Hernandez, Jenny LU ; Lutay, Nataliya LU ; Tammi, Martti; Gustafsson, Mattias LU ; Lundstedt, Ann-Charlotte LU ; Leijonhufvud, Irene LU and Karpman, Diana LU , et al. (2010) In PLoS One 5(5).
Abstract
BACKGROUND: Polymorphisms affecting Toll-like receptor (TLR) structure appear to be rare, as would be expected due to their essential coordinator role in innate immunity. Here, we assess variation in TLR4 expression, rather than structure, as a mechanism to diversify innate immune responses. METHODOLOGY/PRINCIPAL FINDINGS: We sequenced the TLR4 promoter (4,3 kb) in Swedish blood donors. Since TLR4 plays a vital role in susceptibility to urinary tract infection (UTI), promoter sequences were obtained from children with mild or severe disease. We performed a case-control study of pediatric patients with asymptomatic bacteriuria (ABU) or those prone to recurrent acute pyelonephritis (APN). Promoter activity of the single SNPs or multiple... (More)
BACKGROUND: Polymorphisms affecting Toll-like receptor (TLR) structure appear to be rare, as would be expected due to their essential coordinator role in innate immunity. Here, we assess variation in TLR4 expression, rather than structure, as a mechanism to diversify innate immune responses. METHODOLOGY/PRINCIPAL FINDINGS: We sequenced the TLR4 promoter (4,3 kb) in Swedish blood donors. Since TLR4 plays a vital role in susceptibility to urinary tract infection (UTI), promoter sequences were obtained from children with mild or severe disease. We performed a case-control study of pediatric patients with asymptomatic bacteriuria (ABU) or those prone to recurrent acute pyelonephritis (APN). Promoter activity of the single SNPs or multiple allelic changes corresponding to the genotype patterns (GPs) was tested. We then conducted a replication study in an independent cohort of adult patients with a history of childhood APN. Last, in vivo effects of the different GPs were examined after therapeutic intravesical inoculation of 19 patients with Escherichia coli 83972. We identified in total eight TLR4 promoter sequence variants in the Swedish control population, forming 19 haplotypes and 29 genotype patterns, some with effects on promoter activity. Compared to symptomatic patients and healthy controls, ABU patients had fewer genotype patterns, and their promoter sequence variants reduced TLR4 expression in response to infection. The ABU associated GPs also reduced innate immune responses in patients who were subjected to therapeutic urinary E. coli tract inoculation. CONCLUSIONS: The results suggest that genetic variation in the TLR4 promoter may be an essential, largely overlooked mechanism to influence TLR4 expression and UTI susceptibility. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
PLoS One
volume
5
issue
5
publisher
Public Library of Science
external identifiers
  • WOS:000278017300010
  • PMID:20505764
  • Scopus:77956561398
ISSN
1932-6203
DOI
10.1371/journal.pone.0010734
language
English
LU publication?
yes
id
c1d0477d-e10e-492e-bbfc-c9c22d6e8bae (old id 1609870)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20505764?dopt=Abstract
date added to LUP
2010-06-03 08:53:10
date last changed
2016-12-04 04:39:04
@misc{c1d0477d-e10e-492e-bbfc-c9c22d6e8bae,
  abstract     = {BACKGROUND: Polymorphisms affecting Toll-like receptor (TLR) structure appear to be rare, as would be expected due to their essential coordinator role in innate immunity. Here, we assess variation in TLR4 expression, rather than structure, as a mechanism to diversify innate immune responses. METHODOLOGY/PRINCIPAL FINDINGS: We sequenced the TLR4 promoter (4,3 kb) in Swedish blood donors. Since TLR4 plays a vital role in susceptibility to urinary tract infection (UTI), promoter sequences were obtained from children with mild or severe disease. We performed a case-control study of pediatric patients with asymptomatic bacteriuria (ABU) or those prone to recurrent acute pyelonephritis (APN). Promoter activity of the single SNPs or multiple allelic changes corresponding to the genotype patterns (GPs) was tested. We then conducted a replication study in an independent cohort of adult patients with a history of childhood APN. Last, in vivo effects of the different GPs were examined after therapeutic intravesical inoculation of 19 patients with Escherichia coli 83972. We identified in total eight TLR4 promoter sequence variants in the Swedish control population, forming 19 haplotypes and 29 genotype patterns, some with effects on promoter activity. Compared to symptomatic patients and healthy controls, ABU patients had fewer genotype patterns, and their promoter sequence variants reduced TLR4 expression in response to infection. The ABU associated GPs also reduced innate immune responses in patients who were subjected to therapeutic urinary E. coli tract inoculation. CONCLUSIONS: The results suggest that genetic variation in the TLR4 promoter may be an essential, largely overlooked mechanism to influence TLR4 expression and UTI susceptibility.},
  author       = {Ragnarsdottir, Bryndis and Jönsson, Klas and Urbano, Alexander and Grönberg Hernandez, Jenny and Lutay, Nataliya and Tammi, Martti and Gustafsson, Mattias and Lundstedt, Ann-Charlotte and Leijonhufvud, Irene and Karpman, Diana and Wullt, Björn and Truedsson, Lennart and Jodal, Ulf and Andersson, Björn and Svanborg, Catharina},
  issn         = {1932-6203},
  language     = {eng},
  number       = {5},
  publisher    = {ARRAY(0x9b64bb8)},
  series       = {PLoS One},
  title        = {Toll-Like Receptor 4 Promoter Polymorphisms: Common TLR4 Variants May Protect against Severe Urinary Tract Infection.},
  url          = {http://dx.doi.org/10.1371/journal.pone.0010734},
  volume       = {5},
  year         = {2010},
}